Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 121 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Bemarituzumab with chemotherapy for previously untreated advanced gastric or gastroesophageal junction cancer	Bemarituzumab (FPA-144;AMG 552)	Gastric cancer , Gastro-oesophageal junction cancer	Gastrointestinal Cancer	2024	View \| Download
Bevacizumab gamma for treating neovascular age-related macular degeneration	Bevacizumab gamma	Age-related macular degeneration (AMD)	Ophthalmology	2024	View \| Download
BI 1015550 for treating idiopathic pulmonary fibrosis or progressive pulmonary fibrosis	BI 1015550	Idiopathic pulmonary fibrosis , Progressive pulmonary fibrosis	Respiratory System	2024	View \| Download
Blinatumomab with chemotherapy for frontline consolidation treatment of Philadelphia chromosome negative, measurable residual disease negative, B-lineage acute lymphoblastic leukaemia	Blinatumomab (Blincyto) , Chemotherapy	Acute lymphoblastic leukaemia (ALL)	Haematological Cancer and Lymphomas	2024	View \| Download
Brensocatib for people aged 12 and over with non-cystic fibrosis bronchiectasis	Brensocatib (AZD-7986)	Bronchiectasis	Respiratory System	2024	View \| Download
Brentuximab vedotin with chemotherapy (BrECADD) for previously untreated advanced classical Hodgkin lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , Chemotherapy	Hodgkin lymphoma	Haematological Cancer and Lymphomas	2024	View \| Download
Brentuximab vedotin with cyclophosphamide, prednisone and doxorubicin for treating peripheral Tcell lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , Cyclophosphamide (Procytox; cyclophosphamide monohydrate) , Doxorubicin (Livatag; BA-003; Caelyx; Sarcodoxome; SP-1049C; Resmycin; JNS002; doxorubicin hydrochloride) , Prednisone (Decadron; Lodotra)	Peripheral T-cell lymphoma (PTCL)	Haematological Cancer and Lymphomas	2024	View \| Download
Budesonide-glycopyrronium-formoterol fumarate for the treatment of severe and inadequately controlled asthma	Budesonide-glycopyrronium-formoterol fumarate	Asthma	Respiratory System	2024	View \| Download
Cabozantinib for previously treated locally advanced, unresectable or metastatic neuroendocrine tumours	Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184)	Neuroendocrine tumour	Neurological Cancer	2024	View \| Download
Camlipixant for treating refractory or unexplained chronic cough	Camlipixant (NEO-5937; BLU-5937)	Chronic cough	Respiratory System	2024	View \| Download